Endothelial Nitric Oxide Gene Haplotypes and Risk of Cerebral Small-Vessel Disease
- 1 March 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (3) , 654-659
- https://doi.org/10.1161/01.str.0000117238.75736.53
Abstract
Background and Purpose— Genetic influences are important in multifactorial cerebral small-vessel disease (SVD) and may act via endothelial dysfunction. Nitric oxide (NO) synthesized by endothelial nitric oxide synthase (eNOS) is a key mediator of endothelial function. We determined the role of 3 potentially functional eNOS polymorphisms (T-786C, intron 4ab, G894T) located toward the 5′ flanking end of the gene as risk factors for SVD and different SVD subtypes: isolated lacunar infarction (n=137) and ischemic leukoaraiosis (n=160). Methods— Three hundred patients with SVD and 600 community controls were studied. Genotypes were determined through polymerase chain reaction with or without restriction fragment digestion. Nitrate (NOx) levels were determined in a subgroup by use of a Griess method. Polymorphisms were tested individually and in combination with haplotype analysis. Results— The intron 4a variant was protective against SVD. This effect was confined to isolated lacunar infarction (odds ratio, 0.55; 95% confidence interval, 0.35 to 0.86; P=0.01). Haplotypes encountered were significantly different in this subtype compared with controls (P=0.001), with the -786C promoter/intron 4a combination particularly underrepresented. NOx levels were associated with the T-786C locus (P=0.03) but only in the presence of the intron 4a allele (P=0.07 for interaction). Conclusions— The intron 4ab insertion/deletion genotype was associated with isolated lacunar infarction. Haplotype and functional studies suggested that the protective effect of the 4a variant could be mediated through changes in eNOS promoter activity and increased NO levels. The specific association with isolated symptomatic lacunar infarction and not ischemic leukoaraiosis may reflect different etiopathogeneses of the 2 subtypes. Lack of NO could predispose to localized microatheroma in proximal arterioles rather than diffuse arteriosclerosis affecting distal perforating vessels.Keywords
This publication has 19 references indexed in Scilit:
- Haplotype-Specific Effects on Endothelial NO Synthase Promoter EfficiencyArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Faster Haplotype Frequency Estimation Using Unrelated SubjectsHuman Heredity, 2002
- Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humansClinical Science, 2000
- Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRIJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Measurement of nitrite and nitrate levels in plasma and urine — what does this measure tell us about the activity of the endogenous nitric oxite system?Current Opinion in Nephrology and Hypertension, 1998
- A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase geneNature Medicine, 1996
- Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients.Hypertension, 1994
- Nitric Oxide Synthase Inhibition and Cerebrovascular RegulationJournal of Cerebral Blood Flow & Metabolism, 1994
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsAnalytical Biochemistry, 1982